Shares of hVIVO plc (LON:HVO – Get Free Report) rose 10% during mid-day trading on Monday . The company traded as high as GBX 22 ($0.27) and last traded at GBX 21.25 ($0.26). Approximately 7,804,669 shares were traded during mid-day trading, an increase of 164% from the average daily volume of 2,961,263 shares. The stock had previously closed at GBX 19.33 ($0.24).
hVIVO Price Performance
The business’s 50-day simple moving average is GBX 20.01 and its 200-day simple moving average is GBX 25.58. The stock has a market cap of £129.27 million, a PE ratio of 633.33 and a beta of 0.97. The company has a quick ratio of 1.16, a current ratio of 1.61 and a debt-to-equity ratio of 33.86.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
See Also
- Five stocks we like better than hVIVO
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- 3 Tickers Leading a Meme Stock Revival
- 3 Steel Stocks Soaring After Tariff Announcements
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
